# Autophagy: From Molecular Mechanisms to Disease Regulation and Therapeutic Strategies

**Authors:** Huijie Yang, Xinyu Li, Kaidie Wang, Yujiao Zou, Quanjuan Shi, Ya Yang, Qingyun Zhao, Wei Zou

PMC · DOI: 10.3390/cimb48030285 · 2026-03-07

## TL;DR

This review explores how autophagy, a cellular process, influences disease and how it can be targeted for therapies, especially in neurodegenerative and metabolic disorders.

## Contribution

The paper integrates recent findings on autophagy regulation, its role in disease, and microbiota interactions, offering new conceptual frameworks for therapeutic strategies.

## Key findings

- Autophagy acts as a bidirectional modulator in neurodegenerative and metabolic diseases, with both protective and harmful effects.
- Microbial signals via the gut-brain axis influence autophagy responses and disease progression.
- Nanomedicine-based delivery systems are emerging as promising tools for autophagy-targeted therapies.

## Abstract

Autophagy is increasingly recognized as a context-dependent regulatory process that links cellular quality control with systemic metabolic and neurological homeostasis. However, how distinct autophagy pathways contribute to disease progression, and how they are dynamically modulated by host–microbiota interactions, remain incompletely understood. In this review, we synthesize recent advances in the molecular regulation of macroautophagy, microautophagy, and chaperone-mediated autophagy (CMA), with a particular emphasis on selective autophagy and its disease-specific functions. We examine emerging evidence implicating autophagy as a bidirectional modulator in neurodegenerative and metabolic disorders, highlighting conditions under which autophagy exerts protective versus maladaptive effects. Importantly, we integrate recent findings on the microbiota–gut–brain axis to illustrate how microbial signals reshape autophagic responses and influence disease susceptibility and progression. Finally, we summarize current progress and limitations in autophagy-targeted therapeutic strategies, including nanomedicine-based delivery systems, and propose conceptual frameworks to guide the development of precise, context-aware autophagy interventions. This review provides an updated and integrative perspective that bridges molecular mechanisms, host–microbiota crosstalk, and translational opportunities in autophagy-related diseases.

## Full-text entities

- **Genes:** ATG5 (autophagy related 5) [NCBI Gene 9474] {aka APG5, APG5-LIKE, APG5L, ASP, SCAR25, hAPG5}, TBK1 (TANK binding kinase 1) [NCBI Gene 29110] {aka AIARV, FTDALS4, IIAE8, NAK, T2K}, C9orf72 (C9orf72-SMCR8 complex subunit) [NCBI Gene 203228] {aka ALSFTD, DENND9, DENNL72, FTDALS, FTDALS1}, SNAR-E (small NF90 (ILF3) associated RNA E) [NCBI Gene 100170220], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, Snca (synuclein, alpha) [NCBI Gene 20617] {aka NACP, alpha-Syn, alphaSYN}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, OPTN (optineurin) [NCBI Gene 10133] {aka ALS12, FIP2, GLC1E, HIP7, HYPL, NRP}, PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142] {aka ADPRT, ADPRT 1, ADPRT1, ARTD1, PARP, PARP-1}, HSPA8 (heat shock protein family A (Hsp70) member 8) [NCBI Gene 3312] {aka HEL-33, HEL-S-72p, HSC54, HSC70, HSC71, HSP71}, Hab1 [NCBI Gene 55547], AGFG1 (ArfGAP with FG repeats 1) [NCBI Gene 3267] {aka HRB, RAB, RIP}, SIGMAR1 (sigma non-opioid intracellular receptor 1) [NCBI Gene 10280] {aka ALS16, DSMA2, HMNR2, OPRS1, SIG-1R, SR-BP}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, TAX1BP1 (Tax1 binding protein 1) [NCBI Gene 8887] {aka CALCOCO3, T6BP, TXBP151}, GABARAPL1 (GABA type A receptor associated protein like 1) [NCBI Gene 23710] {aka APG8-LIKE, APG8L, ATG8, ATG8B, ATG8L, GEC1}, TFEB (transcription factor EB) [NCBI Gene 7942] {aka ALPHATFEB, BHLHE35, TCFEB}, ADAR (adenosine deaminase RNA specific) [NCBI Gene 103] {aka ADAR1, AGS6, DRADA, DSH, DSRAD, G1P1}, PINK1 (PTEN induced kinase 1) [NCBI Gene 65018] {aka BRPK, PARK6}, RB1CC1 (RB1 inducible coiled-coil 1) [NCBI Gene 9821] {aka ATG17, CC1, FIP200, PPP1R131}, TARDBP (TAR DNA binding protein) [NCBI Gene 23435] {aka ALS10, TDP-43}, TUFM (Tu translation elongation factor, mitochondrial) [NCBI Gene 7284] {aka COXPD4, EF-TuMT, EFTU, P43}, PRKN (parkin RBR E3 ubiquitin protein ligase) [NCBI Gene 5071] {aka AR-JP, LPRS2, PARK2, PDJ}, SNCA (synuclein alpha) [NCBI Gene 6622] {aka NACP, PARK1, PARK4, PD1}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, CAMKK2 (calcium/calmodulin dependent protein kinase kinase 2) [NCBI Gene 10645] {aka CAMKK, CAMKKB}, EP300 (EP300 lysine acetyltransferase) [NCBI Gene 2033] {aka KAT3B, MKHK2, RSTS2, p300}, POM121 (POM121 transmembrane nucleoporin) [NCBI Gene 9883] {aka P145, POM121A}, NUP62 (nucleoporin 62) [NCBI Gene 23636] {aka IBSN, SNDI, p62}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, GABARAP (GABA type A receptor-associated protein) [NCBI Gene 11337] {aka ATG8A, GABARAP-a, MM46}, ATG16L1 (autophagy related 16 like 1) [NCBI Gene 55054] {aka APG16L, ATG16A, ATG16L, IBD10, WDR30}, LRRK2 (leucine rich repeat kinase 2) [NCBI Gene 120892] {aka AURA17, DARDARIN, PARK8, RIPK7, ROCO2}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740] {aka GLP-1, GLP-1-R, GLP-1R}, SOX2 (SRY-box transcription factor 2) [NCBI Gene 6657] {aka ANOP3, MCOPS3}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, ATG12 (autophagy related 12) [NCBI Gene 9140] {aka APG12, APG12L, FBR93, HAPG12}, HTT (huntingtin) [NCBI Gene 3064] {aka HD, IT15, LOMARS}
- **Diseases:** injury to (MESH:D014947), insulin resistance (MESH:D007333), major (MESH:D004830), metabolic dysregulation (MESH:D021081), tumorigenesis (MESH:D063646), DIO (MESH:D009765), T2D (MESH:D003924), NAFLD (MESH:D065626), calcium overload (MESH:D019190), depression (MESH:D003866), diabetic complications (MESH:D048909), neurotoxic (MESH:D020258), PD (MESH:D010300), Neuroinflammation (MESH:D000090862), psychiatric (MESH:D001523), cardiovascular diseases (MESH:D002318), toxicity (MESH:D064420), CMA (MESH:C564093), neurological and metabolic disorders (MESH:D001928), T1D (MESH:D003922), gut dysbiosis (MESH:D064806), Neurodegenerative diseases (MESH:D019636), HD (MESH:D006816), mitochondrial dysfunction (MESH:D028361), diabetes (MESH:D003920), Recognition and Autophagic Transport Deficits (MESH:C536522), glioma (MESH:D005910), Metabolic Diseases (MESH:D008659), paralysis (MESH:D010243), tumor (MESH:D009369), Parkinson (MESH:D010302), chronic (MESH:D002908), glioblastoma (MESH:D005909), loss of neuronal function (MESH:D006315), AD (MESH:D000544), Neurological Disorders (MESH:D009461), infectious diseases (MESH:D003141), MDD (MESH:D003865), energy homeostasis failure (MESH:D051437), metabolic-associated fatty liver illness (MESH:D005234), inflammation (MESH:D007249), Amyotrophic Lateral Sclerosis (MESH:D000690), neuronal loss (MESH:D009410), motor (MESH:D000068079)
- **Chemicals:** PE-P (-), calcium (MESH:D002118), Vitamin D3 (MESH:D002762), lactate (MESH:D019344), rapamycin (MESH:D020123), lipid (MESH:D008055), pentose phosphate (MESH:D010428), NADPH (MESH:D009249), MCC950 (MESH:C000597426), kaempferol (MESH:C006552), ADP (MESH:D000244), pridopidine (MESH:C483720), ROS (MESH:D017382), TMZ (MESH:D000077204), glycogen (MESH:D006003), plasmalogen (MESH:D010955), LPS (MESH:D008070), Urolithin A (MESH:C026423), Metformin (MESH:D008687), chloroquine (MESH:D002738), butyrate (MESH:D002087), SCFA (MESH:D005232)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932]
- **Mutations:** G93A

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13024834/full.md

---
Source: https://tomesphere.com/paper/PMC13024834